Law360, New York (September 14, 2009) -- A judge has signed off on a request to dismiss Upsher-Smith Laboratories Inc., Wockhardt Ltd., Amneal Pharmaceuticals LLC and Apotex Corp. from a patent suit that Forest Laboratories brought to protect the lucrative market for the Alzheimer's drug Namenda from generic competition.
In orders signed Friday, Chief Judge Gregory M. Sleet of the U.S. District Court for the District of Delaware agreed to the stipulations of dismissals in the fight Forest and...
